Related Experiment Video
Updated: May 5, 2026
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
Honokiol as a Radiosensitizing Agent for Colorectal cancers
Zhiyun He1, Dharmalingam Subramaniam, Zhongtao Zhang
1Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China ; Department of General Surgery, Second Hospital of Lanzhou, University of Lanzhou, Gansu 730030, China ; Department of Molecular and Integrative Physiology, Kansas City, Kansas, USA.
Honokiol, a compound from Magnolia, shows potential in increasing colorectal cancer (CRC) sensitivity to radiation therapy. Further research into its mechanisms may reveal new radiosensitizing strategies for CRC patients.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Radiotherapy is a standard treatment for colorectal cancer (CRC).
- Radioresistance in CRC cells presents a significant clinical challenge.
- Developing agents to enhance radiosensitivity is crucial for improving patient outcomes.
Purpose of the Study:
- To review the mechanisms by which honokiol, a Magnolia-derived compound, enhances radiosensitivity in colorectal cancer.
- To explore signaling pathways potentially modulated by honokiol in CRC radiosensitization.
Main Methods:
- Literature review of studies on honokiol and colorectal cancer radiosensitivity.
- Analysis of signaling pathways including cell cycle arrest, tumor angiogenesis, JAK/STAT3, and Mismatch repair.
- In vitro and in vivo studies investigating honokiol's effects on CRC cells.
Main Results:
- Honokiol demonstrates radiosensitizing effects on colorectal cancer cells.
- Honokiol interferes with multiple signaling pathways implicated in radiosensitivity.
- Key pathways affected include cell cycle arrest, angiogenesis, JAK/STAT3 signaling, and DNA mismatch repair.
Conclusions:
- Honokiol acts as a radiosensitizing agent for colorectal cancer.
- Understanding honokiol's mechanism of action involves its modulation of critical signaling pathways.
- This review provides insights into potential therapeutic strategies for overcoming CRC radioresistance.
